Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02117921 · ClinicalTrials.gov registry record · NA
Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain
A NA study, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT02117921 is a NA study that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 20 participants.
The verdict
NCT02117921, a NA study, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.
Interventions
- BEHAVIORAL One-on-one interview and educational sessions. Reading material for educational series provided.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2014-02 |
| Est. Completion | 2016-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02117921
The ClinicalTrials.gov registry entry for NCT02117921 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which One-on-one interview and educational sessions. Reading material for educational series provided. is the first listed.
NCT02117921 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02117921 about?
NCT02117921 is a clinical study titled "Mind Body Syndrome (MBS) Therapy for the Treatment of Chronic Pain". To determine if Mind Body Syndrome (MBS) therapy will reduce or eliminate pain in patients suffering from chronic pain syndromes without organic etiology.
What is the current status of trial NCT02117921?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2014-02. Estimated completion is 2016-12.
What interventions are being tested in trial NCT02117921?
The interventions under investigation include: One-on-one interview and educational sessions. Reading material for educational series provided. (BEHAVIORAL).
Who is sponsoring clinical trial NCT02117921?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.